Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Phase IV, Interventional Study to Assess the Efficacy and Safety of TARGIN(R) (Oxycodone/Naloxone) in Korean Patients With Spinal Disorders

NCT01811238 is registered in ClinicalTrials.gov with Mundipharma Korea Ltd as lead sponsor.

NCT NCT01811238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01811238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Phase IV, Interventional Study to Assess the Efficacy and Safety of TARGIN(R) (Oxycodone/Naloxone) in Korean Patients With Spinal Disorders
Lead sponsor
Mundipharma Korea Ltd
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2012
Completion date
July 31, 2013
Enrollment
240 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

spinal disorders